1Pay S, Erdem H, Pekel A, et al. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behcetg disease. Does interleukin-lbeta play a major role in Behcet's synovitis? [J]. Rheumatol,2006,26(7) :608-613.
2Petrovic-Rackov L, Pejnovic N. Clinical significance of IL-18, IL- 15, IL-12 and TNF-alpha measurement in rheumatoid arthritis [ J]. Clin Rheumatol, 2006,25(4) :448-52.
4Shao XT, Feng L, Gu LJ, et al. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis[J]. Clin Exp Med, 2009, 9(3):215-221.
5Boraschi D, Dinarello CA. IL-18 in autoimmunity: review[J]. Eur Cytokine Netw, 2006, 17(4):224 -252.
6Joosten LA, Radstake TR, Lubberts E, et al. Association of interleukin -18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis [J].Arthritis Rheum, 2003, 48(2) :339-347.
7Bresnihan B, Roux Lombard P, Murphy E, et al. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis[J]. Ann Rheum Dis, 2002, 61(8):726-729.
8Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis [J]. Arthritis Rheum, 2008, 58(10):2958-2967.
9Bokarewa M, Hultgren O. Is interleukin-18 useful for monitoring rheumatoid arthritis [J]? Scand J Rheumatol, 2005, 34(6) :433-436.
10Muhl H, Pfeilschifter J. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory interve- ntion[J]. Eur J Pharmaeol, 2004, 500(1):67 -71.
